ABBOTT PARK, Ill., June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Marking (Conformite Europeenne) in Europe for the TECNIS ® Symfony Extended Range of Vision ...

An expert MD reveals clear insights into cataract surgery, spotlighting the breakthroughs in treatment: "We live in a time of ...

Please provide your email address to receive an email when new articles are posted on . Alcon’s Acrysof IQ PanOptix trifocal IOL has received European CE mark for patients undergoing cataract surgery, ...

Please provide your email address to receive an email when new articles are posted on . Abbott has received CE mark in Europe for its Tecnis Symfony Extended Range of Vision IOL, indicated for ...

Novartis’ Alcon earned a CE mark for its automated, disposable, preloaded intraocular lens delivery system. The company is introducing the device, dubbed AutonoMe, alongside its next-gen Clareon ...

Alcon ALC recently announced that its Clareon Vivity intraocular lens (IOL), featuring extended depth of focus (EDOF) technology, has received CE Mark approval. The lens, made from Alcon's advanced ...

SANTA ANA, Calif., Aug. 22, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today that it has expanded its Healon® family of ophthalmic viscosurgical devices (OVDs) with the European CE Mark of ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--The company Swiss Advanced Vision (SAV-IOL SA - www.sav-iol.com) continues to expand its portfolio of intraocular lenses (IOLs) announcing the launch of a new ...

Corneal refractive surgery has been performed on millions of patients to decrease their spectacle dependence. Most of these patients have high expectations of visual function—but as these patients age ...

Cataract surgery remains one of the most frequently performed and successful surgical procedures worldwide, involving the removal of a clouded natural lens and its replacement with an intraocular lens ...

Among children who underwent unilateral cataract removal in infancy, risk of glaucoma-related adverse events continues to increase with longer follow-up and is not associated with primary intraocular ...